Evidence map›Paper›PMID 27245613›Full record

ArticleScience signaling2016

Protein kinase A-dependent phosphorylation stimulates the transcriptional activity of hypoxia-inducible factor 1.

John W Bullen, Irina Tchernyshyov, Ronald J Holewinski, Lauren DeVine, Fan Wu, Vidya Venkatraman, David L Kass, Robert N Cole, Jennifer Van Eyk, Gregg L Semenza

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects.Cellular and molecular life sciences : CMLS · 2025
    Review
  10. Article
  11. Adrenal epinephrine facilitates erythropoietin gene activation by hypoxia through β2 adrenergic receptor interaction with Hif-2α.American journal of physiology. Regulatory, integrative and comparative physiology · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

John W BullenVascular Program, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Irina TchernyshyovDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Ronald J HolewinskiDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Lauren DeVineDepartment of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Fan WuDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Vidya VenkatramanDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
David L KassDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Robert N ColeDepartment of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Jennifer Van EykDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Gregg L SemenzaVascular Program, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Department of Radiation Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. gsemenza@jhmi.edu.
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

Shared Resource CoresP01HL107153 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI HART, GERALD WARREN · 2011 to 2017
$16.8M
PKG Redox Modulation of Cardiac Function and DiseaseR01HL119012 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI KASS, DAVID ALAN · 2013 to 2016
$1.6M
Characterization of PKA as a critical regulator HIF-1F32GM116326 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI BULLEN, JOHN · 2015 to 2015
$18k
NHLBI NIH HHS HHSN268201000032CNHLBI NIH HHS P01 HL107153NHLBI NIH HHS R01 HL119012NIGMS NIH HHS F32 GM116326
6 · The paper itself

Abstract

Hypoxia-inducible factor 1 (HIF-1) activates the transcription of genes encoding proteins that enable cells to adapt to reduced O2 availability. Proteins encoded by HIF-1 target genes play a central role in mediating physiological processes that are dysregulated in cancer and heart disease. These diseases are also characterized by increased production of cyclic adenosine monophosphate (cAMP), the allosteric activator of cAMP-dependent protein kinase A (PKA). Using glutathione S-transferase pull-down, coimmunoprecipitation, and mass spectrometry analyses, we demonstrated that PKA interacts with HIF-1α in HeLa cervical carcinoma cells and rat cardiomyocytes. PKA phosphorylated Thr(63) and Ser(692) on HIF-1α in vitro and enhanced HIF transcriptional activity and target gene expression in HeLa cells and rat cardiomyocytes. PKA inhibited the proteasomal degradation of HIF-1α in an O2-independent manner that required the phosphorylation of Thr(63) and Ser(692) and was not affected by prolyl hydroxylation. PKA also stimulated the binding of the coactivator p300 to HIF-1α to enhance its transcriptional activity and counteracted the inhibitory effect of asparaginyl hydroxylation on the association of p300 with HIF-1α. Furthermore, increased cAMP concentrations enhanced the expression of HIF target genes encoding CD39 and CD73, which are enzymes that convert extracellular adenosine 5'-triphosphate to adenosine, a molecule that enhances tumor immunosuppression and reduces heart rate and contractility. These data link stimuli that promote cAMP signaling, HIF-1α-dependent changes in gene expression, and increased adenosine, all of which contribute to the pathophysiology of cancer and heart disease.

Indexed as

Transcription, Genetic5'-NucleotidaseAnimalsAntigens, CDApyraseCyclic AMPCyclic AMP-Dependent Protein KinasesDisease ProgressionGlutathione TransferaseGPI-Linked ProteinsHeLa CellsHumansHypoxia-Inducible Factor 1, alpha SubunitImmunosuppression TherapyMiceMyocytes, Cardiac5'-NucleotidaseAntigens, CDApyraseCD39 antigenCyclic AMPCyclic AMP-Dependent Protein KinasesGlutathione TransferaseGPI-Linked ProteinsHIF1A protein, humanHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitNT5E protein, human

Identifiers

PMID27245613
PMCPMC5541497
OpenAlexW2414893019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.